The unified social credit code/registration number of Chengdu Far East Biopharmaceutical Co., Ltd. is 9151kloc-0/00689030428k, and the enterprise is in the opening state.
The business scope of Chengdu Far East Biopharmaceutical Co., Ltd. is: production: small-volume injections, freeze-dried powder injections, tablets, hard capsules and tablets (anti-tumor); Biological and chemical technical consultation; Biotechnology development services; Medical technology research and development; Medical technical consultation; Medical technology transfer; Medical technical services; Information consultation (except investment consultation and intermediary services); Enterprise management consulting; Import and export of goods and technology. (Projects subject to approval according to law can only be operated after approval by relevant departments). (Pharmaceutical Production License is valid until 65438+February 3, 20201). In Sichuan Province, the total registered capital of companies with similar business scope is 1, 632,465,438+0,000 yuan, and the main capital is concentrated in 77 enterprises with the scale of 1, 000-50 million yuan. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
Chengdu Far East Biopharmaceutical Co., Ltd. has invested in 4 foreign-funded companies and 0 branches.
See more information and materials of Chengdu Far East Biopharmaceutical Co., Ltd. through Baidu Enterprise Credit.